Sign Up Today and Learn More About Neuros Medical Stock
Invest in or calculate the value of your shares in Neuros Medical or other pre-IPO companies through EquityZen's platform.

Neuros Medical Stock
Neuros Medical develops neurostimulation therapies for patients suffering with unmet medical needs.
About Neuros Medical Stock
Founded
2008
Headquarters
Willoughby, OH, US
Industries
Software, Artificial Intelligence, Data and Analytics
Neuros Medical Press Mentions
Stay in the know about the latest news on Neuros Medical
Pain Management Devices Market Size to Envision USD 19.10 Billion by 2034
globenewswire • Oct 01, 2025
Neuros Medical Announces First Commercial Implant of the Altius® Direct Electrical Nerve Stimulation System, a Breakthrough Non-Opioid Treatment for Chronic Post-Amputation Pain
prnewswire • Jul 23, 2025
Neuros Medical Scores $56M Series D
vcnewsdaily • Jul 12, 2025
The Week’s 10 Biggest Funding Rounds: Fintech Attracts Biggest Rounds While AI Holds Strong
news • Jul 11, 2025
Neuros Medical Raises $56M in Series D Funding
finsmes • Jul 10, 2025
Neuros Medical Management
Leadership team at Neuros Medical
Board Director
Rem Harris
Vice President, Clinical Programs
Jan Dugas

Join now and verify your accreditation status to gain access to:
- Neuros Medical Current Valuation
- Neuros Medical Stock Price
- Neuros Medical Management
- Available deals in Neuros Medical and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Neuros Medical Cap Table and Funding History by Share Class and Liquidity Preferences
- Neuros Medical Revenue and Financials
- Neuros Medical Highlights
- Neuros Medical Business Model
- Neuros Medical Risk Factors
- Neuros Medical Research Report from SACRA Research
Trading Neuros Medical Stock
How to invest in Neuros Medical stock?
Accredited investors can buy pre-IPO stock in companies like Neuros Medical through EquityZen funds. These investments are made available by existing Neuros Medical shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Neuros Medical stock?
Shareholders can sell their Neuros Medical stock through EquityZen's private company marketplace. EquityZen's network includes over 420K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 51K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."